Impact of Gender on Chronic Complications in Participants With Type 2 Diabetes: Evidence From a Cross‐Sectional Study
Endocrinology, Diabetes & Metabolism · 2024
DOI: 10.1002/edm2.488 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, Diabetes & Metabolism, 2024. Verfasst von Kiavash Mokhtarpour und 7 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Retinopathy. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
This study aimed to assess and compare the prevalence of diabetes complications between men and women with Type 2 diabetes (T2D), as well as how gender relates to these complications.
Methods
In this cross‐sectional study, complications of diabetes, including coronary artery disease (CAD), retinopathy, neuropathy and diabetic kidney disease (DKD), were evaluated in 1867 participants with T2D. Additionally, baseline characteristics of the individuals, including anthropometric measurements, metabolic parameters and the use of dyslipidaemia drugs and antihyperglycaemic agents, were assessed. Gender differences in complications were examined using the chi‐squared test. Multivariate logistic regression was employed to investigate the relationship between gender and T2D complications, with and without adjusting for the characteristics of the studied population.
Results
In the studied population, 62.1% had at least one complication, and complications were 33.5% for DKD, 29.6% for CAD, 22.9% for neuropathy and 19.1% for retinopathy. The prevalence of CAD and neuropathy was higher in men. However, DKD and retinopathy were more prevalent among women. Odds ratios of experiencing any complication, CAD and retinopathy in men compared with women were 1.57 (95% CI: 1.27–2.03), 2.27 (95% CI: 1.72–2.99) and 0.72 (95% CI: 0.52–0.98), respectively, after adjusting for demographic factors, anthropometric measures, metabolic parameters and the consumption of dyslipidaemia drugs and antihyperglycaemic agents.
Conclusion
The prevalence of diabetes complications was significantly higher in men with diabetes, highlighting the need for better treatment adherence. CAD was associated with the male gender, whereas retinopathy was associated with the female gender. Men and women with diabetes should be monitored closely for CAD and retinopathy, respectively, regardless of their age, diabetes duration, anthropometric measures, laboratory findings and medications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Kiavash Mokhtarpour, Amirhossein Yadegar, Seyedeh Nazanin Aghayan, Manouchehr Nakhjavani
Zitieren
APA
Mokhtarpour, K., Yadegar, A., Mohammadi, F., Aghayan, S. N., Seyedi, S. A., Rabizadeh, S., Esteghamati, A., & Nakhjavani, M. (2024). Impact of Gender on Chronic Complications in Participants With Type 2 Diabetes: Evidence From a Cross‐Sectional Study. Endocrinology, Diabetes & Metabolism. https://doi.org/10.1002/edm2.488
Vancouver
Mokhtarpour K, Yadegar A, Mohammadi F, Aghayan SN, Seyedi SA, Rabizadeh S, et al. Impact of Gender on Chronic Complications in Participants With Type 2 Diabetes: Evidence From a Cross‐Sectional Study. Endocrinology, Diabetes & Metabolism. 2024. doi:10.1002/edm2.488
BibTeX
@article{Mokhtarpour2024,
author = {Mokhtarpour, Kiavash and Yadegar, Amirhossein and Mohammadi, Fatemeh and Aghayan, Seyedeh Nazanin and Seyedi, Seyed Arsalan and Rabizadeh, Soghra and Esteghamati, Alireza and Nakhjavani, Manouchehr},
title = {Impact of Gender on Chronic Complications in Participants With Type 2 Diabetes: Evidence From a Cross‐Sectional Study},
journal = {Endocrinology, Diabetes & Metabolism},
year = {2024},
doi = {10.1002/edm2.488}
}
EUVIMED